0781-7313Level 3
Rivastigmine (rivastigmine)
**Product type:** Human Prescription Drug
**Active ingredient:** RIVASTIGMINE
**Strength:** 13.3 mg/24h
**Dosage form:** Patch, Extended Release
**Route:** Transdermal
**Labeler:** Sandoz Inc
**Marketing category:** NDA AUTHORIZED GENERIC (NDA022083)
**Pharmacologic class:** Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/0781-7313Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.